Science Current Events | Science News |

Anti-HIV drug simulation offers 'realistic' tool to predict drug resistance and viral mutation

September 04, 2012

Computer model should help develop better anti-HIV drug combination therapies

Pooling data from thousands of tests of the antiviral activity of more than 20 commonly used anti-HIV drugs, AIDS experts at Johns Hopkins and Harvard universities have developed what they say is the first accurate computer simulation to explain drug effects. Already, the model clarifies how and why some treatment regimens fail in some patients who lack evidence of drug resistance. Researchers say their model is based on specific drugs, precise doses prescribed, and on "real-world variation" in how well patients follow prescribing instructions.

Johns Hopkins co-senior study investigator and infectious disease specialist Robert Siliciano, M.D., Ph.D., says the mathematical model can also be used to predict how well a patient is likely to do on a specific regimen, based on their prescription adherence. In addition, the model factors in each drug's ability to suppress viral replication and the likelihood that such suppression will spur development of drug-resistant, mutant HIV strains.

"With the help of our simulation, we can now tell with a fair degree of certainty what level of viral suppression is being achieved - how hard it is for the virus to grow and replicate - for a particular drug combination, at a specific dosage and drug concentration in the blood, even when a dose is missed," says Siliciano, a professor at the Johns Hopkins University School of Medicine and a Howard Hughes Medical Institute investigator. This information, he predicts, will remove "a lot of the current trial and error, or guesswork, involved in testing new drug combination therapies."

Siliciano says the study findings, to be reported in the journal Nature Medicine online Sept. 2, should help scientists streamline development and clinical trials of future combination therapies, by ruling out combinations unlikely to work.

One application of the model could be further development of drug combinations that can be contained in a single pill taken once a day. That could lower the chance of resistance, even if adherence is not perfect. Such future drug regimens, he says, will ideally strike a balance between optimizing viral suppression and minimizing risk of drug resistance.

Researchers next plan to expand their modeling beyond blood levels of virus to other parts of the body, such as the brain, where antiretroviral drug concentrations can be different from those measured in the blood. They also plan to expand their analysis to include multiple-drug-resistant strains of HIV.

Besides Siliciano, Johns Hopkins joint medical-doctoral student Alireza Rabi was a co-investigator in this study. Other study investigators included doctoral candidates Daniel Rosenbloom, M.S.; Alison Hill, M.S.; and co-senior study investigator Martin Nowak, Ph.D. - all at Harvard University.

Funding support for this study, which took two years to complete, was provided by the National Institutes of Health, with corresponding grant numbers R01-MH54907, R01-AI081600, R01-GM078986; the Bill and Melinda Gates Foundation; the Cancer Research Institute; the National Science Foundation; the Howard Hughes Medical Institute; Natural Sciences and Engineering Research Council of Canada; the John Templeton Foundation; and J. Epstein.

Currently, an estimated 8 million of the more than 34 million people in the world living with HIV are taking antiretroviral therapy to keep their disease in check. An estimated 1,178,000 in the United States are infected, including 23,000 in the state of Maryland.


For additional information, go to:

Johns Hopkins Medicine

Related Combination Therapies Current Events and Combination Therapies News Articles

UA-led research: Prevention of macular degeneration possible
A University of Arizona-led study on age-related macular degeneration - the eye disease that gradually destroys the ability to read, drive, write and see close-up in 30 percent of older Americans - likely will lead to a way to delay or prevent the disease, researchers say.

Treatment restores some function in animal models of spinal muscular atrophy
In work involving several new generations of mouse model development, Jackson Laboratory (JAX) researchers have tested a therapeutic intervention for spinal muscular atrophy (SMA) that restores some function lost due to a mutation in one gene (SMN1) and amplifies the levels of protective genes (SMN2).

Professor Janet Hemingway, outlines 15 years of malaria interventions in Africa
In an editorial in the weekly science journal Nature, LSTM's Director, Professor Janet Hemingway, looks at how the last 15 years of control measures have led to massive reductions in disease prevalence in Africa since 2000.

Breakthrough study demonstrates survival advantage with immune checkpoint inhibitor for advanced kidney cancer patients
For the first time, an immune checkpoint inhibitor has been proven to increase survival among patients with advanced renal cell carcinoma (RCC), a patient population for whom treatment options are currently limited.

Future of HIV cure research points to combination approach
The next five years of HIV research should shift gears from the classic single-therapy development model to moving directly from in vitro studies to combination therapy trials, authors argue in a new paper published online today.

Alzheimer's-disease-related proteases control axonal guidance by regulating growth cone dynamics
Alzheimer's-disease-related proteases, BACE1 and APH1B-y-secretase, control axonal guidance by regulating growth cone dynamics

An antibody that can attack HIV in new ways
Proteins called broadly neutralizing antibodies (bNAbs) are a promising key to the prevention of infection by HIV, the virus that causes AIDS. bNAbs have been found in blood samples from some HIV patients whose immune systems can naturally control the infection.

Clinical trial for first oral drug candidate specifically developed for sleeping sickness
The Drugs for Neglected Diseases initiative (DNDi) has announced today at the 9th European Congress on Tropical Medicine and International Health (ECTMIH) in Basel, Switzerland, the successful completion of Phase I human clinical trials for SCYX-7158 (AN5568), the first oral drug candidate specifically developed from the earliest drug discovery stage to combat human African trypanosomiasis, or sleeping sickness, a deadly parasitic disease transmitted by the tsetse fly.

Researchers find new clue to halting leukemia relapse
A protein domain once considered of little importance may be key to helping patients who are fighting acute myeloid leukemia (AML) avoid a relapse.

Targeted therapy shows effectiveness against a subtype of the brain tumor medulloblastoma
A targeted therapy already used to treat advanced skin cancer is also effective against the most common subtype of the brain tumor medulloblastoma in adults and should be considered for treatment of newly diagnosed patients, according to research led by St. Jude Children's Research Hospital.
More Combination Therapies Current Events and Combination Therapies News Articles

Combination Therapy in Hypertension

Combination Therapy in Hypertension
by Joel M. Neutel (Author)

For over 30 years, the stepped care approach has been used in the management and treatment of hypertension. This approach advocates the use of initial monotherapy to reach the desired blood pressure, and the subsequent use of additional drugs with complementary modes of action, until the target BP is achieved. However, current control rates for hypertension suggest that such an approach may be outdated and no longer effective in the management of hypertension. Clinical trials have shown that more than 50% of patients require a combination of drug therapies to achieve their target BP. Some proponents of combination therapy have argued that the risk of adverse side effects and non-compliance will be lower than that compared to monotherapy, which initially requires higher doses to be...

Hematology - Oncology Therapy

Hematology - Oncology Therapy
by Michael Boyiadzis (Author), James Frame (Author), David R. Kohler (Author), Tito Fojo (Author)

The Essential Therapy Guide to Cancer, Hematologic Disorders, and Supportive Care--Updated with the Latest Treatment Regimens More than 500 treatment regimens Hematology-Oncology Therapy, Second Edition is an up-to-date, comprehensive therapy guide that delivers more than 500 treatment regimens in a succinct, uniform manner. The unique tabular design allows you to instantly locate and implement the proper treatment regimen. Supported by the latest practice guidelines, peer-reviewed literature, and the opinion of experts, Hematology-Oncology Therapy integrates extensive information that is critical to both office- and hospital-based practice of hematology and oncology. Hematology-Oncology Therapy is divided into three sections: Oncology:
Provides detailed information about the...

Textbook of Facial Rejuvenation: The Art of Minimally Invasive Combination Therapy

Textbook of Facial Rejuvenation: The Art of Minimally Invasive Combination Therapy
by Nicholas J. Lowe (Editor), Alastair Carruthers (Editor), Jean Carruthers (Editor), Zoe Diana Draelos (Editor), Richard Glogau (Editor), Christopher Griffiths (Editor), Arnold W. Klein (Editor), Gary Lask (Editor)

In recent years the demand for rejuvenating treatments for the face has grown dramatically for both men and women. Alongside that demand, a wide variety of treatments have evolved, and a combination of different treatments can often result in much greater improvement than single-treatment approaches. With contributions from an impressive cast of international experts, Textbook of Facial Rejuvenation details current treatments, recommends approaches, and suggests how they may be tailored towards individual needs and combined for optimum results.

Conn's Current Therapy 2016, 1e

Conn's Current Therapy 2016, 1e
by Edward T. Bope MD (Author), Rick D. Kellerman MD (Author)

Designed for busy medical practitioners who need a trustworthy, current, and easy-to-use resource, Conn’s Current Therapy 2016 focuses solely on up-to-date treatment protocols for the most common complaints, acute diseases, and chronic illnesses. Covering more than 300 topics, Drs. Edward T. Bope and Rick D. Kellerman present the expertise and knowledge of hundreds of skilled international leaders on evidence-based clinical management options, ensuring you're well equipped with the practical and accurate guidance needed for effective patient care.Expert Consult eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, and references from the book on a variety of devices. Includes PharmD review of newly approved drugs.Brand-new...

Antiepileptic Drugs: Combination Therapy and Interactions

Antiepileptic Drugs: Combination Therapy and Interactions
by Jerzy Majkowski (Editor), Blaise F. D. Bourgeois (Editor), Philip N. Patsalos (Editor), Richard H. Mattson (Editor)

This book reviews the use of antiepileptic drugs focusing on the interactions between these drugs and between antiepileptics and other drugs. These interactions can be beneficial or can cause harm. The aim of this book is to increase awareness of the possible impact of combination pharmacotherapies. Pharmacokinetic and pharmacodynamic interactions are discussed supported by clinical and experimental data. The book consists of five sections covering the general concepts and advantages of combination therapies, the principles of drug interactions, the mechanisms of interactions, drug interactions in specific populations or in patients with co-morbid health conditions, and concludes with a look at the future directions for this field of research. The book will be of interest to all who...

Acupuncture Point Combinations: The Key to Clinical Success, 1e

Acupuncture Point Combinations: The Key to Clinical Success, 1e
by Jeremy Ross (Author)

This book covers the principles and practice of combining acupuncture points - expanding a practitioner's repertoire and increasing their skills - enabling them to use a balanced and appropriate choice of points in the treatment of patients. Information onthe combination of the main points of the fourteen channels is covered in the book prior to outlining specific point combinations for selected disease syndromes. Discussion of combining points according to dermatome theory and according to the energy centres of the body is also discussed, as is combining points for the mind end emotions, and for lifestyle and behaviour. No existing book covers this aspect of clinical practice in such thorough and wide-ranging detail.

Therapy and the Postpartum Woman: Notes on Healing Postpartum Depression for Clinicians and the Women Who Seek their Help

Therapy and the Postpartum Woman: Notes on Healing Postpartum Depression for Clinicians and the Women Who Seek their Help
by Karen Kleiman (Author)

This book provides a comprehensive look at effective therapy for postpartum depression. Using a blend of professional objectivity, evidence-based research, and personal, straight-forward suggestions gathered from years of experience, this book brings the reader into the private world of therapy with the postpartum woman. Based on Psychodynamic and Cognitive-Behavioral theories, and on D.W. Winnicott's "good-enough mother" and the "holding environment" in particular, the book is written by a therapist who has specialized in the treatment of postpartum depression for over 20 years. Therapy and the Postpartum Woman will serve as a companion tool for clinicians and the women they treat.

Prolonged Exposure Therapy for PTSD: Emotional Processing of Traumatic Experiences (Treatments That Work)

Prolonged Exposure Therapy for PTSD: Emotional Processing of Traumatic Experiences (Treatments That Work)
by Edna Foa (Author), Elizabeth Hembree (Author), Barbara Olaslov Rothbaum (Author)

An estimated 70% of adults in the United States have experienced a traumatic event at least once in their lives. Though most recover on their own, up to 20% develop chronic Posttraumatic Stress Disorder. For these people, overcoming PTSD requires the help of a professional.

This guide gives clinicians the information they need to treat clients who exhibit the symptoms of PTSD. It is based on the principles of Prolonged Exposure Therapy, the most scientifically-tested and proven treatment that has been used to effectively treat victims of all types of trauma. Whether your client is a veteran of combat, a victim of a physical or sexual assault, or a casualty of a motor vehicle accident, the techniques and strategies outlined in this book will help.

In this treatment clients...

Combination Therapy: Review on study of interaction of plant extracts or active constituents of plant with antibiotics

Combination Therapy: Review on study of interaction of plant extracts or active constituents of plant with antibiotics
by Piyush Vyas (Author), Arvind Suthar (Author)

Various diseases are caused by micro-organisms in the human beings. There are various ways to treat different types of infectious diseases. Plant based medicines are used for treatment of wide varieties of diseases for thousands of years. Antibiotics are widely used to treat various infectious diseases, but its indiscriminate use has developed the resistance of the micro-organisms. Studies indicates that the efficacy of antibiotics/antimicrobial agents can be improved by combining them with crude plant extracts or active constituents against different pathogens. Combination of various plant extracts or its active constituents with antibiotics is novel concept to fight against resistance problem of micro-organisms. The synergistic effect from the combination of antibiotics with plant...

10 Breakthrough Therapies for Parkinson's Disease: English Edition

10 Breakthrough Therapies for Parkinson's Disease: English Edition
by Michael S Okun MD (Author)

Michael S. Okun, M.D. is internationally celebrated as both a neurologist and a leading researcher. He has often been referred to as, “the voice of the Parkinson’s disease patient.” He was honored at the White House in 2015 as a Champion of Change for Parkinson’s disease. He has an international following on the National Parkinson Foundation’s Ask the Doctor web-forum and he is a Professor of Neurology at the University of Florida Health Center for Movement Disorders and Neurorestoration. His many books and internet blog posts are brimming with up-to date and extremely practical information. This book is the sequel to his runaway bestseller, Parkinson’s Treatment: 10 Secrets to a Happier Life, which was translated into over 20 languages. Dr. Okun is well known for infusing...

© 2015